SCHEMBL26341328

SCHEMBL26341328

O=C(CNc1ccccc1)NNC(=O)c1cc(-c2ccccc2)nn1-c1ccccc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 9/20 0.70
▸ ALDH1A1 P00352 8/20 0.70
▸ SMN1; SMN2 Q16637 2/20 0.70
▸ CXCR5 P32302 1/20 0.70
▸ APLNR P35414 1/20 0.70
▸ CCR6 P51684 1/20 0.70
▸ KDM4E B2RXH2 3/20 0.58
▸ HTT P42858 3/20 0.53
▸ RECQL P46063 1/20 0.53
▸ KMT2A Q03164 3/20 0.52
▸ HPGD P15428 3/20 0.52
▸ MAPT P10636 3/20 0.52
▸ MEN1 O00255 2/20 0.52
▸ L3MBTL1 Q9Y468 1/20 0.52
▸ CYP1A2 P05177 1/20 0.51
▸ CYP2C9 P11712 1/20 0.51
▸ CYP2C19 P33261 1/20 0.51
▸ POLB P06746 1/20 0.50
▸ GRM5 P41594 2/20 0.48
▸ NPSR1 Q6W5P4 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26352208 0.88 LMNA (0.67) LMNAALDH1A1SMN1; SMN2CXCR5APLNR
SCHEMBL27171248 0.82 ALDH1A1 (0.68) LMNAALDH1A1SMN1; SMN2CXCR5APLNR
SCHEMBL26341512 0.82 LMNA (1.00) LMNAALDH1A1SMN1; SMN2CXCR5APLNR
SCHEMBL26341361 0.79 LMNA (0.70) LMNAALDH1A1SMN1; SMN2CXCR5APLNR
SCHEMBL30823697 0.78 LMNA (0.61) LMNAALDH1A1SMN1; SMN2CXCR5APLNR
SCHEMBL26341651 0.78 LMNA (0.61) LMNAALDH1A1SMN1; SMN2CXCR5APLNR
SCHEMBL30823692 0.78 LMNA (0.61) LMNAALDH1A1SMN1; SMN2CXCR5APLNR
SCHEMBL26341735 0.78 LMNA (0.61) LMNAALDH1A1SMN1; SMN2CXCR5APLNR
SCHEMBL16112358 0.78 LMNA (0.72) LMNAALDH1A1SMN1; SMN2CXCR5APLNR
SCHEMBL26341719 0.78 ALDH1A1 (0.68) LMNAALDH1A1SMN1; SMN2CXCR5APLNR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12617771-B2 Diphenylpyrazole compound, and preparation method therefor and application thereof NORTHWEST A&F UNIVERSITY (CN) 2026-05-05 — — US disclosed
US-20240083871-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF NORTHWEST A&F UNIVERSITY (CN) 2024-03-14 — — US disclosed
EP-4249480-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF Northwest A&F University (CN) 2023-09-27 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12617771-B2 Diphenylpyrazole compound, and preparation method therefor and application thereof GSTP1, GSTO1, GSTA1 LMNA 4677/4885ALDH1A1 334/4885SMN1; SMN2 4249/4885
US-20240083871-A1 DIPHENYLPYRAZOLE COMPOUND, AND PREPARATION METHOD THEREFOR AND APPLICATION THEREOF GSTP1, CYP4F11, GSTA1 LMNA 4766/4885ALDH1A1 467/4885SMN1; SMN2 4614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback